XETRA - Delayed Quote EUR

Koninklijke Philips N.V. (PHI1.DE)

Compare
29.55 -0.15 (-0.51%)
At close: October 25 at 5:35 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Roy Jakobs President, CEO & Chairman of the Board of Management 3.61M -- 1974
Dr. Paulus A. Stoffels M.D., Ph.D. Independent Vice Chairman of Supervisory Board & Secretary 172.27k -- 1962
Mr. Marnix J. van Ginneken Executive VP, Chief ESG, Legal Officer & Member of the Board of Management 1.69M -- 1973
Ms. Charlotte Hanneman Executive VP, CFO & Member of Board of Management -- -- --
Mr. Willem Appelo Executive VP & COO -- -- 1964
Mr. Leandro Mazzoni Head of Investor Relations -- -- --
Heidi Sichien Executive VP & Chief People Officer -- -- 1974
Jan Kimpen Chief Medical Officer -- -- 1958
Mr. Pim Preesman Country Leader/ Health Systems Leader Indonesia -- -- --
Mr. Henk Siebren de Jong Executive VP & CEO of Domestic Appliances -- -- 1964

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam, 1096 BC
Netherlands
31 20 597 7777 https://www.philips.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
68,701

Description

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Corporate Governance

Koninklijke Philips N.V.’s ISS Governance QualityScore as of October 1, 2024 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 5; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 28, 2024 at 6:00 AM UTC

Koninklijke Philips N.V. Earnings Date

Recent Events

May 12, 2022 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers